by Sharon O'Reilly
The medical technology arena is home to a number of "game-changing" technologies that initially took the industry by storm only...
Beyond INFUSE: Spine Community Searches For Answers, Alternatives
Medtronic's INFUSE bone morphogenetic protein is the only product in the musculoskeletal industry that has changed the bar in terms of bone healing, and it is under fire for complications related to off-label use. As regulators and payors crack down on INFUSE and hospitals restrict access to the product, surgeons are seeking alternatives and there are a number of companies lining up to fill the void
More from Archive
More from Medtech Insight
• By
A surgeon at Ochsner Health in New Orleans was able to successfully remove a rare and dangerous tumor from a patient’s spine using cutting-edge technology that would have otherwise made the procedure too risky.
• By
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
• By
The FDA's new Commissioner’s National Priority Voucher program aims to expedite drug approvals significantly. Device firms like XVIVO advocate for a similar initiative for devices, emphasizing the potential for faster reviews and improved patient access to lifesaving technologies.